Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis

被引:45
作者
Steinwald, PM
Whang, KT
Becker, KL
Snider, RH
Nylen, ES
White, JC
机构
[1] Vet Affairs Med Ctr, Dept Surg, Washington, DC 20422 USA
[2] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[3] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[4] Vet Affairs Med Ctr, Endocrinol Sect, Washington, DC 20422 USA
[5] George Washington Univ, Med Ctr, Washington, DC 20422 USA
来源
CRITICAL CARE | 1999年 / 3卷 / 01期
关键词
inflammation; peritonitis; procalcitonin; prohormone; serum marker;
D O I
10.1186/cc300
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Increased serum levels of procalcitonin (ProCT) and its component peptides have been reported in humans with sepsis. Using a hamster model of bacterial peritonitis, we investigated whether serum ProCT levels are elevated and correlate with mortality and hypocalcemia. Results: Incremental increases in doses of bacteria resulted in proportional increases in 72 h mortality rates (0, 20, 70, and 100%) as well as increases in serum total immunoreactive calcitonin (iCT) levels at 12 h (250, 380, 1960, and 4020 pg/ml, respectively, vs control levels of 21 pg/ml). Gel filtration studies revealed that ProCT was the predominant (>90%) molecular form of serum iCT secreted. In the metabolic experiments, total iCT peaked at 12 h concurrent with the maximal decrease in serum calcium. Conclusions: In this animal model, hyper-procalcitoninemia was an early systemic marker of sepsis which correlated closely with mortality and had an inverse correlation with serum calcium levels.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 36 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]  
Becker Kenneth L., 1996, P471
[3]   CALCITONIN IN EXTRA-THYROIDAL TISSUES OF MAN [J].
BECKER, KL ;
SNIDER, RH ;
MOORE, CF ;
MONAGHAN, KG ;
SILVA, OL .
ACTA ENDOCRINOLOGICA, 1979, 92 (04) :746-751
[4]  
BECKER KL, 1998, ANN ENDOCRINOL, V59, P170
[5]   DISRUPTION OF THE GOLGI-APPARATUS BY BREFELDIN-A BLOCKS CELL POLARIZATION AND INHIBITS DIRECTED CELL-MIGRATION [J].
BERSHADSKY, AD ;
FUTERMAN, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5686-5689
[6]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[7]   SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393
[9]  
BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cb.03.110187.001331
[10]  
CERRA FB, 1990, ARCH SURG-CHICAGO, V125, P519